New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to...
BEIJING, Aug. 23, 2025 /PRNewswire/ -- Chinese innovation brand ASTRAUX is set to host its Global Launch Event on September 4, 2025, in Berlin, unveiling...
SINGAPORE, Aug. 23, 2025 /PRNewswire/ -- Celebrate the 2025 Mid-Autumn Festival with Jia He, a celebration steeped in tradition. Guests can expect a curated selection...
KUALA LUMPUR, Malaysia, Aug. 23, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) today launches the first edition of its MH Wellness Fair...
LOS ANGELES, Aug. 23, 2025 /PRNewswire/ -- Phone protection is important due to the inevitable drops, scratches, and cracks of everyday life. But what...
CHESTERFIELD, Mo., Aug. 23, 2025 /PRNewswire/ -- It is with deep sadness that we announce the passing of The Rt. Hon. Lord Swraj Paul, a distinguished...
